Document is current

Article History

Received: 24 November 2023

Accepted: 18 October 2024

First Online: 30 October 2024

Declarations

:

: This study was approved by the University of Illinois at Chicago Institutional Review Board (IRB ID: STUDY2020-0169-MOD002). Authors used the summary data from Project HEAL to build an economic model and did not have access to information that could identify individual participants during or after data collection. Informed consent was waived and not required as approved by the UIC. All methods were carried out in accordance with relevant guidelines and regulations.

: Not applicable.

: Daniel R Touchette is the Senior Scientific Advisor for Monument Analytics, a consultant for Astra Zeneca, and has received research funding from AbbVie, Inc and Takeda awarded to University of Illinois Chicago for work unrelated to this study. Sun A Choi was the post-doctoral fellow at University of Illinois Chicago, funded by Takeda and currently is a consultant at Cobbs Creek Healthcare. Kandavadivu Umashankar was a post-doctoral fellow at University of Illinois at Chicago, funded by Takeda and currently has a contractor role at AbbVie, Inc. Michelle Martin has served on advisory boards and serves on the speakers’ bureaus for AbbVie and Gilead, has received grant funding from Merck and Gilead, and is a minor shareholder for AbbVie, Gilead, and Merck. Janet Y Lin has received funding previously from Gilead to implement routine HCV screening in an emergency department setting at University of Illinois Chicago. Anjana Maheswaran, Jean Lee, and Matt Odishoo do not have competing interests.